Breakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis

被引:1
|
作者
Hall, V. G. [2 ,4 ,5 ,7 ]
Lim, C. [1 ]
Saunders, N. R. [1 ]
Klimevski, E. [1 ]
Nguyen, T. H. O. [3 ]
Kedzierski, L. [3 ]
Seymour, J. F. [2 ,4 ,5 ]
Wadhwa, V. [6 ]
Thursky, K. A. [1 ,2 ]
Yong, M. K. [1 ,2 ]
Kedzierska, K. [3 ]
Slavin, M. A. [1 ,2 ]
Teh, B. W. [1 ,2 ]
机构
[1] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Australia
[3] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Australia
[4] Peter MacCallum Canc Ctr, Dept Hematol, Melbourne, Australia
[5] Royal Melbourne Hosp, Melbourne, Australia
[6] Peter MacCallum Canc Ctr, Dept Ambulatory Serv, Melbourne, Australia
[7] Peter MacCallum Canc Ctr, 305 Grattan St, Melbourne 3000, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
D O I
10.1080/10428194.2023.2224472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan
    Mizuki Haraguchi
    Hisashi Yamamoto
    Otoya Watanabe
    Takashi Sakoh
    Keiko Ishida
    Sho Ogura
    Masayo Katoh-Morishima
    Yuki Taya
    Aya Nishida
    Daisuke Kaji
    Shinsuke Takagi
    Go Yamamoto
    Naoyuki Uchida
    Hideki Araoka
    Bone Marrow Transplantation, 2023, 58 : 1051 - 1053
  • [2] Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan
    Haraguchi, Mizuki
    Yamamoto, Hisashi
    Watanabe, Otoya
    Sakoh, Takashi
    Ishida, Keiko
    Ogura, Sho
    Katoh-Morishima, Masayo
    Taya, Yuki
    Nishida, Aya
    Kaji, Daisuke
    Takagi, Shinsuke
    Yamamoto, Go
    Uchida, Naoyuki
    Araoka, Hideki
    BONE MARROW TRANSPLANTATION, 2023, 58 (09) : 1051 - 1053
  • [3] Pre-exposure immunization by tixagevimab/cilgavimab in hematological malignancy and covid-19 in the epicovideha registry
    Salmanton-Garcia, J.
    Marchesi, F.
    Buquicchio, C.
    Itri, F.
    Besson, C.
    Rahimli, L.
    Glenthoj, A.
    Cornely, O. A.
    Pagano, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 291 - 292
  • [4] Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1641): : 1 - 2
  • [5] Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection
    Sindu, Devika
    Razia, Deepika
    Grief, Katherine
    Cherrier, Lauren
    Omar, Ashraf
    Walia, Rajat
    Tokman, Sofya
    TRANSPLANTATION DIRECT, 2023, 9 (06): : E1485
  • [6] Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19
    Abramowicz, Mark
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 384 - 385
  • [7] Early Experience of Breakthrough COVID-19 Infections in Patients Who Received Pre-exposure Prophylaxis with Tixagevimab/cilgavimab
    Calabrese, Cassandra
    Kirchner, Elizabeth
    Forte, Alexandra Villa
    Hajj-Ali, Rula
    Langford, Carol
    Fernandez, James
    Carlson, Alise
    Moss, Brandon
    Sayles, Vickie
    Pallotta, Andrea
    Kim, Alice
    Calabrese, Leonard
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1549 - 1550
  • [8] COVID-19 pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with haematological malignancy: A single-centre experience
    Lee, Kee Tat
    Low, Woei Chyuan
    Tan, Sui Keat
    Chiang, Su Kien
    Chew, Teng Keat
    Goh, Ai Sim
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 167 - 167
  • [9] Risk factors for breakthrough COVID-19 infections in solid organ transplant recipients receiving tixagevimab/cilgavimab for pre-exposure prophylaxis
    Abraham, Dana L.
    Lichvar, Alicia B.
    Brubaker, Aleah L.
    Haste, Nina
    Chen, Victor
    Abeles, Shira
    Aslam, Saima
    Yam, Nancy
    Horton, Lucy
    Chen, Benjamin
    Binkin, Nancy
    Law, Nancy
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [10] COVID-19 pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with haematological malignancy: A single-centre experience
    Lee, Kee Tat
    Low, Woei Chyuan
    Tan, Sui Keat
    Chiang, Su Kien
    Chew, Teng Keat
    Goh, Ai Sim
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 167 - 167